Cambridge Investment Research Advisors’s iShares Global Healthcare ETF IXJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.25M Sell
13,327
-4,880
-27% -$478K ﹤0.01% 1976
2025
Q4
$1.77M Sell
18,207
-2,521
-12% -$239K ﹤0.01% 1634
2025
Q3
$1.84M Sell
20,728
-426
-2% -$36.8K 0.01% 1565
2025
Q2
$1.82M Buy
21,154
+4,029
+24% +$347K 0.01% 1497
2025
Q1
$1.56M Sell
17,125
-3,999
-19% -$363K 0.01% 1512
2024
Q4
$1.82M Sell
21,124
-41,912
-66% -$3.87M 0.01% 1426
2024
Q3
$6.19M Buy
63,036
+37,499
+147% +$3.64M 0.02% 701
2024
Q2
$2.37M Sell
25,537
-212
-0.8% -$19.3K 0.01% 1176
2024
Q1
$2.4M Buy
25,749
+699
+3% +$63.2K 0.01% 1154
2023
Q4
$2.17M Sell
25,050
-725
-3% -$60.1K 0.01% 1147
2023
Q3
$2.12M Sell
25,775
-163
-0.6% -$13.8K 0.01% 1099
2023
Q2
$2.21M Buy
25,938
+3,592
+16% +$306K 0.01% 1113
2023
Q1
$1.86M Buy
22,346
+8,389
+60% +$695K 0.01% 1167
2022
Q4
$1.19M Buy
13,957
+6
+0% +$495 0.01% 1400
2022
Q3
$1.05M Sell
13,951
-40,958
-75% -$3.31M 0.01% 1439
2022
Q2
$4.46M Buy
54,909
+40,101
+271% +$3.35M 0.02% 631
2022
Q1
$1.3M Sell
14,808
-41,516
-74% -$3.51M 0.01% 1399
2021
Q4
$5.09M Buy
56,324
+38,597
+218% +$3.34M 0.02% 634
2021
Q3
$1.48M Buy
17,727
+888
+5% +$76.8K 0.01% 1252
2021
Q2
$1.4M Buy
16,839
+39
+0.2% +$3.15K 0.01% 1313
2021
Q1
$1.29M Buy
16,800
+248
+1% +$19.1K 0.01% 1264
2020
Q4
$1.26M Buy
16,552
+2,492
+18% +$183K 0.01% 1167
2020
Q3
$1.01M Sell
14,060
-2,914
-17% -$209K 0.01% 1185
2020
Q2
$1.17M Sell
16,974
-3,505
-17% -$237K 0.01% 1033
2020
Q1
$1.25M Sell
20,479
-34,961
-63% -$2.31M 0.01% 868
2019
Q4
$3.81M Buy
55,440
+38,163
+221% +$2.48M 0.03% 562
2019
Q3
$1.05M Sell
17,277
-1,490
-8% -$91.1K 0.01% 1040
2019
Q2
$1.16M Sell
18,767
-35,397
-65% -$2.12M 0.01% 954
2019
Q1
$3.31M Buy
54,164
+35,929
+197% +$2.14M 0.03% 521
2018
Q4
$1.03M Buy
18,235
+2,983
+20% +$179K 0.01% 919
2018
Q3
$961K Buy
15,252
+1,531
+11% +$92.5K 0.01% 1045
2018
Q2
$774K Sell
13,721
-17,911
-57% -$1.01M 0.01% 1131
2018
Q1
$1.76M Buy
31,632
+2,208
+8% +$127K 0.02% 669
2017
Q4
$1.66M Buy
29,424
+4,272
+17% +$240K 0.02% 652
2017
Q3
$1.41M Buy
25,152
+258
+1% +$14.2K 0.02% 672
2017
Q2
$1.36M Buy
24,894
+376
+2% +$20K 0.02% 662
2017
Q1
$1.26M Buy
24,518
+900
+4% +$45.1K 0.02% 629
2016
Q4
$1.12M Buy
23,618
+1,930
+9% +$92.5K 0.02% 619
2016
Q3
$1.09M Buy
21,688
+122
+0.6% +$6.27K 0.02% 642
2016
Q2
$1.09M Sell
21,566
-344
-2% -$17.2K 0.02% 569
2016
Q1
$1.05M Sell
21,910
-2,230
-9% -$106K 0.02% 549
2015
Q4
$1.24M Buy
24,140
+1,840
+8% +$94.7K 0.03% 490
2015
Q3
$1.1M Sell
22,300
-3,556
-14% -$192K 0.03% 454
2015
Q2
$1.41M Buy
25,856
+3,778
+17% +$208K 0.04% 403
2015
Q1
$1.19M Buy
22,078
+2,250
+11% +$118K 0.03% 448
2014
Q4
$987K Buy
19,828
+306
+2% +$15.2K 0.03% 486
2014
Q3
$954K Buy
19,522
+5,246
+37% +$251K 0.03% 543
2014
Q2
$673K Sell
14,276
-558
-4% -$25.6K 0.02% 603
2014
Q1
$675K Buy
14,834
+1,276
+9% +$56.9K 0.03% 572
2013
Q4
$584K Buy
13,558
+2,106
+18% +$87.5K 0.02% 592
2013
Q3
$455K Sell
11,452
-152
-1% -$5.95K 0.02% 667
2013
Q2
$431K Buy
+11,604
New +$442K 0.02% 605

Other funds holding IXJ